Q4 Results 2022: Central Bank, UPL, PVR, BLS International, Suven Pharma announce March quarter results; here are key highlights

Q4 Results 2022: Many listed companies announced their March quarter results on Monday. Central Bank of India, UPL, PVR Limited, BLS International Services and Suven Pharmaceuticals were among the companies which declared their quarterly earnings. Here are key highlights!

Central Bank of India Q4 Results 2022: CBI reports Rs 310 cr net profit in March quarter; FY22 net at Rs 1,045 cr. Source: IANS

Q4 Results 2022: Many listed companies announced their March quarter results on Monday. Central Bank of India, UPL, PVR Limited, BLS International Services Limited and Suven Pharmaceuticals Limited were among the companies which declared their quarterly earnings. Here are key highlights!

Central Bank of India Q4 Results 2022: CBI reports Rs 310 cr net profit in March quarter; FY22 net at Rs 1,045 cr

State-owned Central Bank of India on Monday reported a standalone net profit of Rs 310 crore in quarter ended March 2022, on the back of less provisioning for bad loans.

TRENDING NOW

The lender had posted a net loss of Rs 1,349 crore in the same quarter a year-ago.

Total income during Q4 of FY22 rose to Rs 6,419.58 crore, from Rs 5,729.38 crore in the same period of FY21, Central Bank of India said in a regulatory filing.

For the full fiscal year 2021-22, the bank witnessed a turnaround and recorded a net profit of Rs 1,045 crore. It had a net loss of Rs 888 crore in 2020-21.

Total income during the year rose to Rs 25,770.13 crore, from Rs 25,845.90 crore in FY21.

The lender improved on its asset quality and brought down the gross non-performing assets (NPAs) to 14.84 per cent of the gross advances at the end of March 2022, as against 16.55 per cent in the year-ago period.

Net NPAs or bad loans fell to 3.97 per cent, from 5.77 per cent.

Fall in bad loan proportions significantly reduced to Rs 1,061 crore for Q4FY22, as against Rs 3,080 crore put aside for the year-ago quarter.

For the full year, the provisioning for contingencies reduced to Rs 3,480 crore, from Rs 5,902 crore.

The bank's total business increased to Rs 5,32,404 crore, from Rs 5,06,886 crore registering a growth of 5.03 per cent year-on-year, it said.

Total deposits have increased by Rs 12,719 crore and stood at Rs 3,42,692 crore as on March 31, 2022, as compared to Rs 3,29,973 crore, reflecting an increase of 3.85 per cent, said the lender.

Credit cost for FY22 improved from 2.95 per cent to 1.41 per cent, registering an improvement of 154 basis points (bps) yera-on-year.

Slippage Ratio for the fiscal year 2021-22 stood at 3.20 per cent, compared to 4.40 per cent during the previous fiscal year, registering an improvement of 120 bps, it said.

Further, the bank said that the business per employee for FY22 has increased from Rs 15.60 crore, to Rs 17.15 crore on an yearly basis, registering a rise of nearly 10 per cent.

Stock of Central Bank of India were trading at Rs 18.10 apiece on BSE, down by 1.63 per cent from previous close.

PVR Q4 Results 2022: Company reports net loss of Rs 105.49 cr in March quarter, revenue at Rs 537.14 cr

Leading multiplex chain operator PVR Ltd on Monday reported narrowing of its consolidated net loss to Rs 105.49 crore for the fourth quarter ended in March 2022.

The company had posted a net loss of Rs 289.21 crore in the January-March quarter a year ago, PVR said in a BSE filing.

Its revenue from operations rose by nearly three-fold to Rs 537.14 crore during the quarter under review as against Rs 181.46 crore in the corresponding quarter last fiscal.

Its total expenses were at Rs 731.17 crore, up 43.91 per cent in Q4/FY 2021-22 as against Rs 508.07 crore in the year-ago quarter.

Shares of PVR Ltd on Monday were trading at Rs 1,688.30 apiece on BSE, down 0.73 per cent, from the previous close.

See Zee Business Live TV Streaming Below:

BLS International Q4 Results 2022: PAT up 53% at Rs 35.2 cr

BLS International on Monday reported a 53 per cent growth in profit after tax (PAT) to Rs 35.2 crore for the quarter ended in March 2022 compared to the year-ago period.

The company's PAT stood at Rs 23 crore during the corresponding quarter of 2020-21, BLS International said in a statement.

Operational revenue grew by 75.5 per cent during the quarter under review to Rs 253.8 crore from Rs 144.6 crore in the same period of FY21.

For the full 2021-22 fiscal, PAT surged by over two-fold to Rs 111.2 crore compared to Rs 50.3 crore in FY21. Operational revenue went up by 77.7 per cent to Rs 849.9 crore in FY22 from Rs 478.4 crores in FY21.

"At a full year level, we have delivered exceptional performance by signing new contracts with various governments across our businesses.

"Our domestic projects in Punjab, Uttar Pradesh, Rajasthan and Starfin continue to outperform while Visa services has shown tremendous resilience and consular services have surpassed pre-COVID levels of business performance. We expect sustained momentum with the opening up of borders and increased appetite for global travel," BLS International Joint Managing Director Shikhar Aggarwal said.

Shares of the company on Monday closed at Rs 340, down 2.05 per cent on BSE.

Suven Pharma Q4 Results 2022: net up 11% at Rs 92 cr

Suven Pharmaceuticals on Monday said its consolidated profit after tax has increased by 11 per cent to Rs 92 crore for the fourth quarter ended March.

The company had reported a profit after tax (PAT) of Rs 83 crore in the January-March quarter of 2020-21 fiscal.

Revenue from operations rose to Rs 364 crore in the fourth quarter as against Rs 259 crore in the same period of previous fiscal, Suven Pharmaceuticals said in a regulatory filing.

For the year ended March 31, 2022, the drug firm reported a PAT of Rs 454 crore as compared with Rs 362 crore in FY21.

Revenue from operations rose to Rs 1,320 crore as against Rs 1,010 crore in the 2020-21 financial year.

The Hyderabad-based company said its board has approved second interim dividend of Re 1 per share (100 per cent) and a one-time special dividend of Re 1 per share, totalling to Rs 2 for the financial year 2021-22.

UPL Q4 Results 2022: net up 29% at Rs 1,379 cr

Agro-chemicals major UPL on Monday reported a 29 per cent growth in net profit at Rs 1,379 crore for the quarter ended March.

The company's net profit stood at Rs 1,065 crore in the corresponding quarter of the previous financial year, UPL said in a statement.

Revenue grew by 24 per cent to Rs 15,860 crore, compared to Rs 12,797 crore in the year-ago period.

For the full fiscal 2021-22, UPL's net profit grew by 26 per cent to Rs 3,626 crore, as against Rs 2,872 crore in the preceding fiscal.

The company's revenue in FY22 climbed 19 per cent to Rs 46,240 crore from Rs 38,694 crore earlier.

"We are delighted to share a strong set of results for Q4 2022, and another record year for UPL. Thanks to the dedication, agility and tenacity of our team, we have been able to significantly outperform the guidance given at the start of the year, with nearly every region seeing double-digit growth.

"FY22 was a year of challenging macro-environment, input cost inflationary pressures and supply chain disruptions and we chose to prudently invest towards ensuring reliable growth going forward," company CEO Jai Shroff said.

Guided by its OpenAg purpose to create sustainable growth for all, UPl achieved important milestones in its mission to build a network that 'reimagines sustainability' for the entire agricultural industry, he added.

"In a significant achievement for this mission, our digital platform nuture.Farm became the first company to successfully forward sell agricultural-related carbon credits in India," he said.

Shares of the company on Monday were trading at Rs 778.05 in the afternoon session, down 1.11 per cent on BSE.

TAGS: